Chronic Pain Clinical Trial
Official title:
The Effectiveness of Cognitive Functional Therapy in Adults With Chronic Neck Pain: A Pragmatic Randomized Controlled Trial
Verified date | February 2024 |
Source | European University Cyprus |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study was to compare the effectiveness of Cognitive Functional Therapy compared with Conventional Therapy in treating adults with chronic neck pain
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 30, 2024 |
Est. primary completion date | April 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - Age 18-64 - Pain in neck area for more than 3 months - Pain in NPRS more than 40/100 - Independently mobile (with or without aids), to be capable of participating in a rehabilitation program twice a week Exclusion Criteria: - Serious psychological pathology - recently surgery on shoulder or neck area (<6 months) - Pain relieving procedures such as injection based therapy (e.g epidurals) and day case procedures (e.g rhizotomy) in the last 3 months - Pregnancy - Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease) - Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease (PD), motor neuron disease (MND) - Unstable cardiac conditions - Red flag disorders like malignancy/cancer, acute traumas like fracture (<6 months ago) or infection, spinal cord compression/cauda equina |
Country | Name | City | State |
---|---|---|---|
Cyprus | European University of Cyprus | Nicosia | Engomi |
Lead Sponsor | Collaborator |
---|---|
European University Cyprus |
Cyprus,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Numerical rating scale | Measured pain intensity with 0 no pain and 100 the worst pain ever. | Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Primary | Neck Disability Index | This questionnaire has been designed to give us information as to how your neck pain has affected your ability to manage in everyday life.
0= no disability 100= severe disability |
Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Secondary | Fear Avoidance Beliefs Questionnaire | The Fear-Avoidance Beliefs Questionnaire (FABQ) is a patient reported questionnaire which specifically focuses on how a patient's fear avoidance beliefs about physical activity and work may affect and contribute to their low back pain and resulting disability.
The questionnaire consists of 16 items in which a patient rates their agreement with each statement on a 7-point Likert scale. Where 0= completely disagree, 6=completely agree. There is a maximum score of 96. A higher score indicates more strongly held fear avoidance beliefs. |
Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Secondary | Short Fort 12 | The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning | Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Secondary | EurQqol 5 | An EQ-5D health state is the set of responses to the 5 dimensions of EQ-5D, as completed by a patient or respondent.
Values are anchored at 1 (full health) and 0 (a state as bad as being dead) as required by their use in economic evaluation. Values less than 0 represent health states regarded as worse than a state that is as bad as being dead. |
Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Secondary | Range of motion | Range of motion in all cervical movement, flexion, extension, side flexion, rotations | Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) | |
Secondary | Isometric Strength | Strength in all cervical movement, flexion, extension, side flexion, rotations | Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|